Cargando…

A 4-Benzene-Indol Derivative Alleviates LPS-Induced Acute Lung Injury Through Inhibiting the NLRP3 Inflammasome

Acute lung injury (ALI) is a common complication of critical illness that could frequently lead to acute respiratory distress syndrome and other serious clinical consequences. Sepsis is one of the major and most common inducements among all causes of ALI. Due to its high incidence and mortality rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Junmei, Bai, Yang, Tang, Yiting, Wang, Xiangyu, Cavagnaro, María José, Li, Ling, Li, Zhaozheng, Zhang, Yi, Shi, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866853/
https://www.ncbi.nlm.nih.gov/pubmed/35222388
http://dx.doi.org/10.3389/fimmu.2022.812164
_version_ 1784655923009028096
author Li, Junmei
Bai, Yang
Tang, Yiting
Wang, Xiangyu
Cavagnaro, María José
Li, Ling
Li, Zhaozheng
Zhang, Yi
Shi, Jian
author_facet Li, Junmei
Bai, Yang
Tang, Yiting
Wang, Xiangyu
Cavagnaro, María José
Li, Ling
Li, Zhaozheng
Zhang, Yi
Shi, Jian
author_sort Li, Junmei
collection PubMed
description Acute lung injury (ALI) is a common complication of critical illness that could frequently lead to acute respiratory distress syndrome and other serious clinical consequences. Sepsis is one of the major and most common inducements among all causes of ALI. Due to its high incidence and mortality rate and also the complexity in treatment, sepsis-related ALI has become an urgent clinical problem waiting to be solved effectively. At present, only the protective ventilation strategy, restrictive fluid management, and antibiotics application are measures that can improve the prognosis with evidence-based medical proof. No pharmacological treatment is currently available to protect or significantly reverse the prognosis. Seeking for effective interventions measures for sepsis-related ALI is one of the most necessitous research directions. In this research, a conspicuous discovery of treatment-related translational use for a 4-benzene-indol derivative was elaborated by screening a large number of chemical compounds. The results showed that 4-benzene-indol derivative could not only suppress the activation of NLRP3 inflammasome both in vitro and alleviate LPS-induced ALI in vivo but also suppress the NLRP3 inflammasome in human myeloid leukemia mononuclear cells (THP-1) cell lines. Mechanistically, 1,2-diol blocks the NLRP3 inflammasome activation by disrupting NLRP3–NEK7 interaction and the subsequent NLRP3 inflammasome assembly and activation. To summarize, this research indicated that the newly-discovered 4-benzene-indol derivative targets NLRP3 inflammasome signaling, which consequently alleviates sepsis-related ALI. Collectively, the 4-benzene-indol derivative may serve as a potential therapeutic drug and NLRP3 inflammasome signaling would be a novel pharmaceutical target for clinical treatment of sepsis-related ALI.
format Online
Article
Text
id pubmed-8866853
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88668532022-02-25 A 4-Benzene-Indol Derivative Alleviates LPS-Induced Acute Lung Injury Through Inhibiting the NLRP3 Inflammasome Li, Junmei Bai, Yang Tang, Yiting Wang, Xiangyu Cavagnaro, María José Li, Ling Li, Zhaozheng Zhang, Yi Shi, Jian Front Immunol Immunology Acute lung injury (ALI) is a common complication of critical illness that could frequently lead to acute respiratory distress syndrome and other serious clinical consequences. Sepsis is one of the major and most common inducements among all causes of ALI. Due to its high incidence and mortality rate and also the complexity in treatment, sepsis-related ALI has become an urgent clinical problem waiting to be solved effectively. At present, only the protective ventilation strategy, restrictive fluid management, and antibiotics application are measures that can improve the prognosis with evidence-based medical proof. No pharmacological treatment is currently available to protect or significantly reverse the prognosis. Seeking for effective interventions measures for sepsis-related ALI is one of the most necessitous research directions. In this research, a conspicuous discovery of treatment-related translational use for a 4-benzene-indol derivative was elaborated by screening a large number of chemical compounds. The results showed that 4-benzene-indol derivative could not only suppress the activation of NLRP3 inflammasome both in vitro and alleviate LPS-induced ALI in vivo but also suppress the NLRP3 inflammasome in human myeloid leukemia mononuclear cells (THP-1) cell lines. Mechanistically, 1,2-diol blocks the NLRP3 inflammasome activation by disrupting NLRP3–NEK7 interaction and the subsequent NLRP3 inflammasome assembly and activation. To summarize, this research indicated that the newly-discovered 4-benzene-indol derivative targets NLRP3 inflammasome signaling, which consequently alleviates sepsis-related ALI. Collectively, the 4-benzene-indol derivative may serve as a potential therapeutic drug and NLRP3 inflammasome signaling would be a novel pharmaceutical target for clinical treatment of sepsis-related ALI. Frontiers Media S.A. 2022-02-10 /pmc/articles/PMC8866853/ /pubmed/35222388 http://dx.doi.org/10.3389/fimmu.2022.812164 Text en Copyright © 2022 Li, Bai, Tang, Wang, Cavagnaro, Li, Li, Zhang and Shi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Li, Junmei
Bai, Yang
Tang, Yiting
Wang, Xiangyu
Cavagnaro, María José
Li, Ling
Li, Zhaozheng
Zhang, Yi
Shi, Jian
A 4-Benzene-Indol Derivative Alleviates LPS-Induced Acute Lung Injury Through Inhibiting the NLRP3 Inflammasome
title A 4-Benzene-Indol Derivative Alleviates LPS-Induced Acute Lung Injury Through Inhibiting the NLRP3 Inflammasome
title_full A 4-Benzene-Indol Derivative Alleviates LPS-Induced Acute Lung Injury Through Inhibiting the NLRP3 Inflammasome
title_fullStr A 4-Benzene-Indol Derivative Alleviates LPS-Induced Acute Lung Injury Through Inhibiting the NLRP3 Inflammasome
title_full_unstemmed A 4-Benzene-Indol Derivative Alleviates LPS-Induced Acute Lung Injury Through Inhibiting the NLRP3 Inflammasome
title_short A 4-Benzene-Indol Derivative Alleviates LPS-Induced Acute Lung Injury Through Inhibiting the NLRP3 Inflammasome
title_sort 4-benzene-indol derivative alleviates lps-induced acute lung injury through inhibiting the nlrp3 inflammasome
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866853/
https://www.ncbi.nlm.nih.gov/pubmed/35222388
http://dx.doi.org/10.3389/fimmu.2022.812164
work_keys_str_mv AT lijunmei a4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT baiyang a4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT tangyiting a4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT wangxiangyu a4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT cavagnaromariajose a4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT liling a4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT lizhaozheng a4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT zhangyi a4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT shijian a4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT lijunmei 4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT baiyang 4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT tangyiting 4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT wangxiangyu 4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT cavagnaromariajose 4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT liling 4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT lizhaozheng 4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT zhangyi 4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome
AT shijian 4benzeneindolderivativealleviateslpsinducedacutelunginjurythroughinhibitingthenlrp3inflammasome